Recruiting
Phase 1

Calaspargase Pegol-Mnkl and Cobimetinib for the Treatment of Locally Advanced or Metastatic Pancreatic Cancer

Sponsor:

OHSU Knight Cancer Institute

Code:

NCT05034627

Conditions

Locally Advanced Pancreatic Adenocarcinoma

Metastatic Pancreatic Adenocarcinoma

Stage II Pancreatic Cancer AJCC v8

Stage IIA Pancreatic Cancer AJCC v8

Stage IIB Pancreatic Cancer AJCC v8

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Biopsy

Calaspargase Pegol-mknl

Cobimetinib

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information